Physician profile
Zayed Almadidy
NPI 1518498716
$53,398.40
in general payments reported to CMS, 2019-2025
16 companies · $9,951 in 2025
The $9,951 reported for 2025 was more than what 85% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.23 · 2021: $283 · 2022: $1,664 · 2023: $18K · 2024: $23K · 2025: $9,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $23K · Grant: $20K · Food and Beverage: $8,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $22,501.38 |
| Grant | $20,000.00 |
| Food and Beverage | $8,917.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20,022.20 | 2024 | Eterna |
| Alphatec Spine, INC | $14,194.27 | 2022-2025 | Other - Miscellaneous, Identiti |
| Globus Medical, INC. | $5,253.37 | 2023-2025 | Xlif, Reline, Corbel |
| Stryker Corporation | $4,232.83 | 2019-2023 | Everest Spinal System, Cascadia Interbody System |
| Depuy Synthes Sales INC. | $3,787.72 | 2021-2023 | Teligen, X-Pac, Fibergraft Bg Morsels |
| Medical Device Business Services, INC. | $1,978.74 | 2022-2023 | Symphony |
| Zavation Medical Products, LLC | $1,608.27 | 2025 | |
| Mirus, LLC | $1,316.58 | 2024 | Europa Pedicle Screw System |
| Medtronic, INC. | $365.47 | 2025 | Unid_pass |
| Davol INC. | $207.64 | 2023 | |
| Orthofix Medical, INC. | $151.97 | 2021-2025 | Cervical-Stim, Spinal-Stim |
| Lemaitre Vascular, INC. | $103.26 | 2023 | Restoreflow |
| Theragen, INC. | $101.00 | 2025 | Actastim-S |
| Penumbra, INC. | $60.00 | 2023 | Red 72 |
| C2dx, INC | $15.08 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$38,079.03 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zayed Almadidy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.